Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Lone Hvitfeldt, Poulsen"'
Autor:
Lone Hvitfeldt Poulsen, Bryce A. Kerlin, Giancarlo Castaman, Angelo Claudio Molinari, Marzia Menegatti, Diane Nugent, Sohan Dey, May‐Lill Garly, Manuel Carcao
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 2, Pp n/a-n/a (2022)
Abstract Background Regular factor XIII (FXIII) prophylaxis is standard treatment for congenital FXIII A‐subunit deficiency (FXIII‐A CD). Recombinant factor XIII‐A2 (rFXIII‐A2) was extensively evaluated in the mentor trials. Objective To asse
Externí odkaz:
https://doaj.org/article/5a6d8df7f0b441e8a7dd4b247b17f799
Autor:
Pål Andre Holme, Karina Meijer, Claude Negrier, Shadan Lalezari, Ingrid Pabinger, Monika Maas Enriquez, Maria Wang, Lone Hvitfeldt Poulsen, Mark T. Reding, Pavani Chalasani, Maria Elisa Mancuso
Publikováno v:
Haemophilia, 27(3), E347-E356. Wiley
Reding, M T, Pabinger, I, Holme, P A, Poulsen, L, Negrier, C, Chalasani, P, Maas Enriquez, M, Wang, M, Meijer, K, Mancuso, M E & Lalezari, S 2021, ' Confirmed long-term safety and efficacy of prophylactic treatment with BAY 94–9027 in severe haemophilia A : final results of the PROTECT VIII extension study ', Haemophilia, vol. 27, no. 3, pp. e347-e356 . https://doi.org/10.1111/hae.14297
Reding, M T, Pabinger, I, Holme, P A, Poulsen, L, Negrier, C, Chalasani, P, Maas Enriquez, M, Wang, M, Meijer, K, Mancuso, M E & Lalezari, S 2021, ' Confirmed long-term safety and efficacy of prophylactic treatment with BAY 94–9027 in severe haemophilia A : final results of the PROTECT VIII extension study ', Haemophilia, vol. 27, no. 3, pp. e347-e356 . https://doi.org/10.1111/hae.14297
Introduction: The phase 2/3 PROTECT VIII main study demonstrated efficacy and safety of BAY 94–9027 (damoctocog alfa pegol; Jivi®), a B-domain-deleted recombinant factor VIII (FVIII), site-specifically PEGylated to extend its half-life. Aim: To re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65fe46cdd05e2e5c47cfc2c11d9447fd
https://doi.org/10.1111/hae.14297
https://doi.org/10.1111/hae.14297
Autor:
Amy D. Shapiro, Pantep Angchaisuksiri, Jan Astermark, Gary Benson, Giancarlo Castaman, Hermann Eichler, Victor Jiménez-Yuste, Kaan Kavakli, Tadashi Matsushita, Lone Hvitfeldt Poulsen, Allison P. Wheeler, Guy Young, Silva Zupančić-Šalek, Johannes Oldenburg, Pratima Chowdary
Publikováno v:
Shapiro, A D, Angchaisuksiri, P, Astermark, J, Benson, G, Castaman, G, Eichler, H, Jiménez-Yuste, V, Kavakli, K, Matsushita, T, Poulsen, L H, Wheeler, A P, Young, G, Zupančić-Šalek, S, Oldenburg, J & Chowdary, P 2022, ' Long-term efficacy and safety of subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors ', Blood Advances, vol. 6, no. 11, pp. 3422-3432 . https://doi.org/10.1182/bloodadvances.2021006403
Despite current therapies, there remains an unmet need for treatment for patients with hemophilia. The main parts of two phase 2 trials established clinical proof-of-concept for once-daily, subcutaneous concizumab prophylaxis in patients with hemophi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f757ec65c47eeb7f5127acc4d2660912
https://hdl.handle.net/11454/77786
https://hdl.handle.net/11454/77786
Autor:
Kasper Korsholm, Andreas Kristensen, Lone Hvitfeldt Poulsen, Anders Kramer, Jens Erik Nielsen-Kudsk
Publikováno v:
Kramer, A D, Korsholm, K, Kristensen, A, Poulsen, L H & Nielsen-Kudsk, J E 2021, ' Left atrial appendage occlusion in haemophilia patients with atrial fibrillation ', Journal of Interventional Cardiac Electrophysiology . https://doi.org/10.1007/s10840-021-01090-z
PURPOSE: Advanced targeted therapy has resulted in increasing life expectancy and incidence of age-related cardiovascular diseases like atrial fibrillation in patients with haemophilia. Oral anticoagulation constitutes a significant dilemma in this p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13c45c927b11b724cc0fcf2bdc929b7d
https://pure.au.dk/portal/da/publications/left-atrial-appendage-occlusion-in-haemophilia-patients-with-atrial-fibrillation(ca424922-4d56-46f6-a413-6b005aae6400).html
https://pure.au.dk/portal/da/publications/left-atrial-appendage-occlusion-in-haemophilia-patients-with-atrial-fibrillation(ca424922-4d56-46f6-a413-6b005aae6400).html
Publikováno v:
Berntorp, E, Hermans, C, Solms, A, Poulsen, L & Mancuso, M E 2021, ' Optimising prophylaxis in haemophilia A : The ups and downs of treatment ', Blood Reviews, vol. 50, 100852 . https://doi.org/10.1016/j.blre.2021.100852
The classical goals of haemophilia A treatment are to prevent bleeds, minimise the risk of long-term complications associated with joint damage, and improve quality of life by maintaining appropriate factor VIII [FVIII] levels. The dose and frequency
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2ae41612e5175e5b4dbee5f7ddd106e
https://pure.au.dk/portal/da/publications/optimising-prophylaxis-in-haemophilia-a(960bd916-1234-4521-9547-50329414a5a9).html
https://pure.au.dk/portal/da/publications/optimising-prophylaxis-in-haemophilia-a(960bd916-1234-4521-9547-50329414a5a9).html
Autor:
Anders Dahl, Kramer, Kasper, Korsholm, Andreas, Kristensen, Lone Hvitfeldt, Poulsen, Jens Erik, Nielsen-Kudsk
Publikováno v:
Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing. 64(1)
Advanced targeted therapy has resulted in increasing life expectancy and incidence of age-related cardiovascular diseases like atrial fibrillation in patients with haemophilia. Oral anticoagulation constitutes a significant dilemma in this patient ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::40df158a88c6b1feeed1088bf41e1873
https://pubmed.ncbi.nlm.nih.gov/34822042
https://pubmed.ncbi.nlm.nih.gov/34822042
Autor:
Terkel Andersen, Emilie B. Ingvorsen, Jakob B. Bjorner, Lars Lehrmann, Lone Hvitfeldt Poulsen, Christina Schnohr, Karen Binger Holm, Eva Funding, Jan Gerstoft, Alex Lund Laursen
Publikováno v:
BMC Public Health, Vol 19, Iss 1, Pp 1-9 (2019)
Ingvorsen, E B, Schnohr, C, Andersen, T, Lehrmann, L, Funding, E, Poulsen, L H, Holm, K B, Laursen, A L, Gerstoft, J & Bjorner, J B 2019, ' "Development in well-being and social function among Danish hemophilia patients with HIV: a three-wave panel study spanning 24 years" ', B M C Public Health, vol. 19, 1714 . https://doi.org/10.1186/s12889-019-8062-9
Ingvorsen, E B, Schnohr, C, Andersen, T, Lehrmann, L, Funding, E, Poulsen, L H, Holm, K B, Laursen, A L, Gerstoft, J & Bjorner, J B 2019, ' "Development in well-being and social function among Danish hemophilia patients with HIV : a three-wave panel study spanning 24 years" ', BMC Public Health, vol. 19, no. 1, 1714 . https://doi.org/10.1186/s12889-019-8062-9
BMC Public Health
Ingvorsen, E B, Schnohr, C, Andersen, T, Lehrmann, L, Funding, E, Poulsen, L H, Holm, K B, Laursen, A L, Gerstoft, J & Bjorner, J B 2019, ' "Development in well-being and social function among Danish hemophilia patients with HIV: a three-wave panel study spanning 24 years" ', B M C Public Health, vol. 19, 1714 . https://doi.org/10.1186/s12889-019-8062-9
Ingvorsen, E B, Schnohr, C, Andersen, T, Lehrmann, L, Funding, E, Poulsen, L H, Holm, K B, Laursen, A L, Gerstoft, J & Bjorner, J B 2019, ' "Development in well-being and social function among Danish hemophilia patients with HIV : a three-wave panel study spanning 24 years" ', BMC Public Health, vol. 19, no. 1, 1714 . https://doi.org/10.1186/s12889-019-8062-9
BMC Public Health
Background Between 1975 and 1985 a total of 91 Danish patients with moderate and severe hemophilia (PWH) was infected with HIV constituting a major scandal in the Danish health care system. This study describes the burden of HIV infection among Danis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f30e8548791788810bb05bbb51ad56e2
https://doaj.org/article/25ab93cabcac4aca9aed24c442cebcef
https://doaj.org/article/25ab93cabcac4aca9aed24c442cebcef
Autor:
Steven R. Lentz, Manuel Carcao, Allison P. Wheeler, Pratima Chowdary, Judi Møss, Pål Andre Holme, Víctor Jiménez-Yuste, Lone Hvitfeldt Poulsen, Alberto Tosetto, Elena Santagostino, Chunduo Shen
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 3, Iss 3, Pp 542-554 (2019)
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis
Background N8‐GP is an extended half‐life recombinant factor VIII developed for prophylaxis and treatment of bleeds in patients with hemophilia A. Objective To assess pharmacokinetic (PK) characteristics of N8‐GP in previously treated patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c27d21935acf7968981101605f013c70
https://doaj.org/article/9e72b2ac203c43c88c631ec0301b622f
https://doaj.org/article/9e72b2ac203c43c88c631ec0301b622f
Autor:
Lone Hvitfeldt, Poulsen, Bryce A, Kerlin, Giancarlo, Castaman, Angelo Claudio, Molinari, Marzia, Menegatti, Diane, Nugent, Sohan, Dey, May-Lill, Garly, Manuel, Carcao
Publikováno v:
Research and practice in thrombosis and haemostasis. 6(2)
Regular factor XIII (FXIII) prophylaxis is standard treatment for congenital FXIII A-subunit deficiency (FXIII-A CD). Recombinant factor XIII-ATo assess real-world safety and treatment effectiveness of rFXIII-Amentor 6 was a noninterventional, postau
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8ca013747953076f2c32caa8fbf312a5
https://pubmed.ncbi.nlm.nih.gov/35243202
https://pubmed.ncbi.nlm.nih.gov/35243202
Autor:
Elena Santagostino, Heng Joo Ng, Shadan Lalezari, Lisa A. Michaels, Jonathan M. Ducore, Camila Linardi, Lone Hvitfeldt Poulsen, Mark T. Reding
Publikováno v:
Santagostino, E, Lalezari, S, Reding, M T, Ducore, J, Ng, H J, Poulsen, L H, Michaels, L A & Linardi, C 2021, ' Safety and efficacy of BAY 94–9027, an extended-half-life factor VIII, during minor surgical procedures in patients with severe haemophilia A ', Haemophilia, vol. 27, no. 4, pp. e559-e562 . https://doi.org/10.1111/hae.14319
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92316895d8d3d1ae85bfa02a9dc4b5eb
https://doi.org/10.1111/hae.14319
https://doi.org/10.1111/hae.14319